TBTruong An Bui

Truong An Bui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Truong An Bui has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early Transcriptional Changes in Neutrophil‐Mediated Processes Following Recanalization After Ischemic Stroke

    by Truong An Bui, Yonglie Ma, Glen C. Jickling, Ian R. Winship

    Background: Ischemic stroke is a leading cause of death and long‐term disability worldwide. Recanalization therapies, including thrombolysis and mechanical thrombectomy, restore blood flow, yet many patients experience poor outcomes, a phenomenon known as futile recanalization. Given the short therapeutic window for ischemic stroke, identifying early biomarkers to guide targeted interventions and improve outcomes is critical. Methods: Using a murine middle cerebral occlusion model that mimics a large vessel occlusion with recanalization, a comprehensive microarray analysis from blood samples collected immediately and 3 hours after recanalization (N=44) was performed. Differentially expressed genes, enrichment pathways, immune cell proportions, enriched cell markers, predicted micro‐RNAs, and transcription factors were identified using RStudio. Findings in mice were validated with rat middle cerebral artery occlusion (GSE21136) and patients with stroke (GSE16561) data sets to confirm transcriptional changes in peripheral blood postrecanalization. Results: Il1r2 , Cd55 , Mmp8 , Cd14 , and Cd69 were early biomarkers poststroke and postrecanalization. Cross‐validation revealed Vcan as a differentially expressed gene conserved across species, making it a novel ischemic marker detected as early as 3 hours postrecanalization (4 hours after middle cerebral artery occlusion) in mice, 24 hours after recanalization in rats (middle cerebral artery occlusion‐thrombectomy), and within 24 hours from onset in humans receiving recombinant tissue plasminogen activator‐thrombolysis. CIBERSORTx and ImmuCellAI‐mouse deconvolution showed neutrophil elevation postrecanalization. Leukocyte and neutrophil activation pathways were enriched early after stroke in mice and humans, with stronger upregulation in the female sex. Several regulatory micro‐RNAs were identified, and Nuclear Factor Erythroid 4 (NFE4) and Metal Regulatory Transcription Factor 1 (MTF1) emerged as key transcription factors. A coregulatory network underlying neutrophil activity was constructed, highlighting its central role in early responses to ischemia and recanalization, which was enriched in the female sex. Conclusions: We identified novel early genomic markers for ischemia and recanalization, including the conserved marker Vcan , and highlighted age‐ and sex‐specific immune responses. Mapping a neutrophil‐centered coregulatory network provides mechanistic insight into futile recanalization and supports the development of targeted therapies to improve clinical outcomes.


  • Open Access

    Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder

    by Truong An Bui, Benjamin R. O’cRoinin, Liz Dennett, Ian R. Winship, Andrew J. Greenshaw

    Despite being one of the most common and debilitating mood disorders, bipolar disorder is often misdiagnosed and undertreated. Its pathogenesis is complex, with significant patient variability and inconsistent treatment effectiveness. The brain-gut-microbiota axis plays a critical role in bipolar disorder by modulating neurotransmitter secretion, gut peptides and systemic inflammation. However, the mechanisms by which psychotropic treatments influence gut microbiota composition and their implications for clinical outcomes remain poorly understood. This systematic review evaluated the impact of psychotropic drugs on gut microbiota and their potential role in bipolar disorder treatment outcomes. A comprehensive search across Ovid MEDLINE, Embase, APA PsycINFO, Scopus and PubMed yielded 314 articles, of which 12 met the inclusion criteria (last search: 13 August 2024). The studies included were those on adults with bipolar disorder type I or II receiving psychopharmacological treatments; those with group comparisons (e.g. healthy controls vs. medicated vs. non-medicated) investigating gut microbiome changes; and no restrictions applied to psychotic features, comorbid anxiety or prior treatment responses. Exclusions involved individual case reports, incomplete conference submissions or early terminated studies lacking efficacy analysis. Cochrane ROBINS-I V2 tool was used to measure the risk of bias, and the GRADE approach was utilized to rate the certainty of evidence in included studies. Two authors independently extracted data into Excel spreadsheets, categorizing demographic and clinical characteristics, describing microbiome analytic methods and summarizing findings on gut microbiome changes post-treatment. Given the high variability in methods and outcome measures across studies, all details were reported without data conversion. Data synthesis reveals that psychotropic treatments, including quetiapine and lithium, influence gut microbiota by increasing the abundance of beneficial bacteria supporting gut health and pathogenic bacteria linked to metabolic dysfunction. Notably, female patients exhibited more significant changes in microbial diversity following psychotropic treatment. Additionally, patients treated with psychotropics showed an increased prevalence of gut bacteria associated with multidrug antibiotic resistance. In bipolar patients treated with quetiapine, responders – those experiencing improved depressive symptom scores – displayed distinct gut microbiome profiles more closely resembling those of healthy individuals compared with non-responders. Responders also exhibited neural connectivity patterns similar to healthy subjects. These findings underscore the complex dual impact of psychotropic medications on gut microbiota, with potential consequences for both gut and mental health. While the enrichment of beneficial bacteria may support gut health, the rise in antibiotic-resistant and metabolically disruptive bacteria is concerning. Study limitations include methodological heterogeneity, inclusions of other psychiatric disorders, a high risk of bias in some studies due to incomplete statistical analyses or insufficient control for confounding factors and potential duplication of study populations arising from overlapping authorship. Further research is essential to elucidate the functional consequences of these microbial shifts and their influence on treatment efficacy. Nevertheless, this review highlights the potential of utilizing gut microbiota profiles to inform personalized treatment strategies, optimize therapeutic outcomes and minimize side effects in bipolar disorder. This study was registered with Open Science Framework (https://doi.org/10.17605/OSF.IO/3GUZR).


  • Open Access

    Pharmaco-psychiatry and gut microbiome: A systematic review of effects of psychotropic drugs for bipolar disorder

    by Truong An Bui, Benjamin R. O’croinin, Liz Dennett, Ian R. Winship, Andrew Greenshaw, Elizabeth Dennett

    Despite being one of the most common and debilitating mood disorders, bipolar disorder is often misdiagnosed and undertreated. Its pathogenesis is complex, with significant patient variability and inconsistent treatment effectiveness. The brain-gut-microbiota axis plays a critical role in bipolar disorder by modulating neurotransmitter secretion, gut peptides, and systemic inflammation. However, the mechanisms by which psychotropic treatments influence gut microbiota composition and their implications for clinical outcomes remain poorly understood. This systematic review evaluated the impact of psychotropic drugs on gut microbiota and their potential role in bipolar disorder treatment outcomes. A comprehensive search across Ovid MEDLINE, Embase, APA PsycINFO, Scopus, and PubMed yielded 314 articles, of which 12 met the inclusion criteria (last search: 13 August 2024). The studies included were those on adults with bipolar disorder type I or II receiving psychopharmacological treatments, those with group comparisons (e.g., medicated vs. non-medicated) investigating gut microbiome changes; no restrictions applied to psychotic features, comorbid anxiety, or prior treatment responses. Exclusions involved individual case reports, incomplete conference submissions, or early terminated studies lacking efficacy analysis. Cochrane ROBINS-I V2 tool was used to measure the risk of bias, and the GRADE approach was utilized to rate the certainty of evidence in included studies. Two authors independently extracted data into Excel spreadsheets, categorizing demographic and clinical characteristics, describing microbiome analytic methods, and summarizing findings on gut microbiome changes post-treatment. Given the high variability in methods and outcome measures across studies, all details were reported without data conversion. Data synthesis reveals that psychotropic treatments, including quetiapine and lithium, influence gut microbiota by increasing the abundance of beneficial bacteria supporting gut health and pathogenic bacteria linked to metabolic dysfunction. Notably, female patients exhibited more significant changes in microbial diversity following psychotropic treatment. Additionally, patients treated with psychotropics showed an increased prevalence of gut bacteria associated with multidrug antibiotic resistance. In bipolar patients treated with quetiapine, responders—those experiencing improved depressive symptom scores—displayed distinct gut microbiome profiles more closely resembling those of healthy individuals compared to non-responders. Responders also exhibited neural connectivity patterns similar to healthy subjects. These findings underscore the complex dual impact of psychotropic medications on gut microbiota, with potential consequences for both gut and mental health. While the enrichment of beneficial bacteria may support gut health, the rise in antibiotic-resistant and metabolically disruptive bacteria is concerning. Study limitations include methodological heterogeneity, a high risk of bias in some studies due to incomplete statistical analyses or insufficient control for confounding factors, and potential duplication of study populations arising from overlapping authorship. Further research is essential to elucidate the functional consequences of these microbial shifts and their influence on treatment efficacy. Nevertheless, this review highlights the potential of utilizing gut microbiota profiles to inform personalized treatment strategies, optimize therapeutic outcomes, and minimize side effects in bipolar disorder.


  • Open Access

    Early transcriptional changes in neutrophil-mediated processes following recanalization after ischemic stroke

    by Truong An Bui, Yonglie Ma, Glen C Jickling, Ian R Winship

    Background: Ischemic stroke is a leading cause of mortality and long-term disability globally. Recanalization therapies restore blood flow by thrombolysis and/or mechanical thrombectomy. Despite successful recanalization, many patients still experience poor clinical outcomes. This phenomenon, known as futile recanalization, may result from reperfusion injury and microcirculatory failure. Given the short therapeutic window for ischemic stroke, it is critical to identify early biomarkers that could be targeted to minimize pathology and extend the therapeutic window to improve clinical outcomes. Methods: Using a murine middle cerebral occlusion (MCAO) model that mimics a large vessel occlusion with recanalization, a comprehensive microarray analysis of gene expression from blood samples collected immediately and 3 hours after recanalization (N=44) was performed. Differentially expressed genes (DEGs), enrichment pathways, immune cell proportions, enriched cell markers, and predicted miRNAs and transcription factors were identified using RStudio. Findings in mice were validated in datasets of rat MCAO stroke (GSE21136) and human stroke patients (GSE16561) to confirm transcriptional changes in peripheral blood post-recanalization. Results: Il1r2, Cd55, Mmp8, Cd14, and Cd69 were identified as early biomarkers in blood after stroke and recanalization. Further, cross-validation revealed Vcan as a DEG conserved across species, making it a novel marker of ischemia detected as early as 3 hours post-recanalization (4 hours post-MCAO) in mice, 24 hours after recanalization in rats (MCAO-thrombectomy), and within 24 hours from onset in humans receiving rtPA-thrombolysis. Using human (CIBERSORTx) and murine (ImmuCellAI-mouse) cell deconvolution reference datasets, neutrophil was elevated post-recanalization. Leukocyte and neutrophil activation pathways were significantly enriched early after stroke in mouse and human samples, with a stronger upregulation observed in females of both species. The analysis revealed several key miRNAs involved in gene regulation following recanalization; NFE4 and MTF1 emerged as essential transcription factors in these processes. Based on these data, a coregulatory network underlying neutrophil activity was constructed, highlighting its central role in early responses to ischemia and recanalization, which was enriched in females. Conclusions: This study identified new early genomic markers in the blood for ischemia and recanalization, as well as critical age- and sex-specific factors. By mapping a coregulatory network of interacting genes and neutrophil-related pathways, as well as identifying the novel marker Vcan , the data provides insights to inform future research and develop targeted therapies. Such therapies can improve treatment efficacy or modulate neutrophils to reduce futile recanalization, ultimately enhancing clinical outcomes for ischemic stroke patients. Graphical Clinical and research perspectives: This study identifies Il1r2, Cd55, Mmp8, Cd14, Cd69 , and Vcan as novel, early blood biomarkers of ischemic stroke and reperfusion injury following recanalization. Notably, Vcan was conserved across rodent and human models, underscoring its translational potential. These peripheral hemo-genomic signatures hold promise as biomarkers to help identify patients at higher risk of futile recanalization, thereby enabling earlier, more tailored clinical interventions to reduce reperfusion injury and improve recovery. The significant increase in neutrophil proportions, demonstrated through deconvolution of both human and murine reference datasets, supports prior evidence implicating neutrophil aggregation in reperfusion failure and highlights this cell type as a key target for further investigation. Moreover, the pronounced neutrophil-related transcriptional responses in females suggest that sex-specific mechanisms may influence stroke outcomes and warrant consideration in therapeutic design in acute stroke management. At the mechanistic level, the study reveals a core gene regulatory network—centred on neutrophil-associated genes, transcription factors NFE4 and MTF1, and stroke-associated miRNAs—that orchestrates early immune responses to ischemia and recanalization. Collectively, these findings suggest potentially predictive molecular signatures of reperfusion failure following recanalization. Future studies could investigate whether targeting these regulatory elements can prevent futile recanalization, thus improving long-term functional outcomes.

  • Open Access

    Developing a Chatbot to Support Individuals With Neurodevelopmental Disorders: Tutorial

    by Ashwani Singla, Ritvik Khanna, Manpreet Kaur, Karen Kelm, Osmar Zaiane, Cory Scott Rosenfelt, Truong An Bui, Navid Rezaei, David Nicholas, Marek Z Reformat, et al.

    Families of individuals with neurodevelopmental disabilities or differences (NDDs) often struggle to find reliable health information on the web. NDDs encompass various conditions affecting up to 14% of children in high-income countries, and most individuals present with complex phenotypes and related conditions. It is challenging for their families to develop literacy solely by searching information on the internet. While in-person coaching can enhance care, it is only available to a minority of those with NDDs. Chatbots, or computer programs that simulate conversation, have emerged in the commercial sector as useful tools for answering questions, but their use in health care remains limited. To address this challenge, the researchers developed a chatbot named CAMI (Coaching Assistant for Medical/Health Information) that can provide information about trusted resources covering core knowledge and services relevant to families of individuals with NDDs. The chatbot was developed, in collaboration with individuals with lived experience, to provide information about trusted resources covering core knowledge and services that may be of interest. The developers used the Django framework (Django Software Foundation) for the development and used a knowledge graph to depict the key entities in NDDs and their relationships to allow the chatbot to suggest web resources that may be related to the user queries. To identify NDD domain–specific entities from user input, a combination of standard sources (the Unified Medical Language System) and other entities were used which were identified by health professionals as well as collaborators. Although most entities were identified in the text, some were not captured in the system and therefore went undetected. Nonetheless, the chatbot was able to provide resources addressing most user queries related to NDDs. The researchers found that enriching the vocabulary with synonyms and lay language terms for specific subdomains enhanced entity detection. By using a data set of numerous individuals with NDDs, the researchers developed a knowledge graph that established meaningful connections between entities, allowing the chatbot to present related symptoms, diagnoses, and resources. To the researchers’ knowledge, CAMI is the first chatbot to provide resources related to NDDs. Our work highlighted the importance of engaging end users to supplement standard generic ontologies to named entities for language recognition. It also demonstrates that complex medical and health-related information can be integrated using knowledge graphs and leveraging existing large datasets. This has multiple implications: generalizability to other health domains as well as reducing the need for experts and optimizing their input while keeping health care professionals in the loop. The researchers' work also shows how health and computer science domains need to collaborate to achieve the granularity needed to make chatbots truly useful and impactful.


  • Open Access

    Developing a Chatbot to Support Individuals With Neurodevelopmental Disorders: Tutorial (Preprint)

    by Ashwani Singla, Ritvik Khanna, Manpreet Kaur, Karen Kelm, Osmar Zaiane, Cory Scott Rosenfelt, Truong An Bui, Navid Rezaei, David Nicholas, Marek Z Reformat, et al.

    UNSTRUCTURED Families of individuals with neurodevelopmental disabilities or differences (NDDs) often struggle to find reliable health information on the web. NDDs encompass various conditions affecting up to 14% of children in high-income countries, and most individuals present with complex phenotypes and related conditions. It is challenging for their families to develop literacy solely by searching information on the internet. While in-person coaching can enhance care, it is only available to a minority of those with NDDs. Chatbots, or computer programs that simulate conversation, have emerged in the commercial sector as useful tools for answering questions, but their use in health care remains limited. To address this challenge, the researchers developed a chatbot named CAMI (Coaching Assistant for Medical/Health Information) that can provide information about trusted resources covering core knowledge and services relevant to families of individuals with NDDs. The chatbot was developed, in collaboration with individuals with lived experience, to provide information about trusted resources covering core knowledge and services that may be of interest. The developers used the Django framework (Django Software Foundation) for the development and used a knowledge graph to depict the key entities in NDDs and their relationships to allow the chatbot to suggest web resources that may be related to the user queries. To identify NDD domain–specific entities from user input, a combination of standard sources (the Unified Medical Language System) and other entities were used which were identified by health professionals as well as collaborators. Although most entities were identified in the text, some were not captured in the system and therefore went undetected. Nonetheless, the chatbot was able to provide resources addressing most user queries related to NDDs. The researchers found that enriching the vocabulary with synonyms and lay language terms for specific subdomains enhanced entity detection. By using a data set of numerous individuals with NDDs, the researchers developed a knowledge graph that established meaningful connections between entities, allowing the chatbot to present related symptoms, diagnoses, and resources. To the researchers’ knowledge, CAMI is the first chatbot to provide resources related to NDDs. Our work highlighted the importance of engaging end users to supplement standard generic ontologies to named entities for language recognition. It also demonstrates that complex medical and health-related information can be integrated using knowledge graphs and leveraging existing large datasets. This has multiple implications: generalizability to other health domains as well as reducing the need for experts and optimizing their input while keeping health care professionals in the loop. The researchers' work also shows how health and computer science domains need to collaborate to achieve the granularity needed to make chatbots truly useful and impactful.


  • Open Access

    Long-term Memory Testing in Children With Typical Development and Neurodevelopmental Disorders: Remote Web-based Image Task Feasibility Study

    by Truong An Bui, Cory Scott Rosenfelt, Kerri Hope Whitlock, Mickael Leclercq, Savannah Weber, Arnaud Droit, Sandra A Wiebe, Jacqueline Pei, Francois V Bolduc

    Background: Neurodevelopmental disorders (NDD) cause individuals to have difficulty in learning facts, procedures, or social skills. NDD has been linked to several genes, and several animal models have been used to identify potential therapeutic candidates based on specific learning paradigms for long-term and associative memory. In individuals with NDD, however, such testing has not been used so far, resulting in a gap in translating preclinical results to clinical practice. Objective: We aim to assess if individuals with NDD could be tested for paired association learning and long-term memory deficit, as shown in previous animal models. Methods: We developed an image-based paired association task, which can be performed at different time points using remote web-based testing, and evaluated its feasibility in children with typical development (TD), as well as NDD. We included 2 tasks: object recognition as a simpler task and paired association. Learning was tested immediately after training and also the next day for long-term memory. Results: We found that children aged 5-14 years with TD (n=128) and with NDD of different types (n=57) could complete testing using the Memory Game. Children with NDD showed deficits in both recognition and paired association tasks on the first day of learning, in both 5-9–year old (P<.001 and P=.01, respectively) and 10-14–year old groups (P=.001 and P<.001, respectively). The reaction times to stimuli showed no significant difference between individuals with TD or NDD. Children with NDD exhibited a faster 24-hour memory decay for the recognition task than those with TD in the 5-9–year old group. This trend is reversed for the paired association task. Interestingly, we found that children with NDD had their retention for recognition improved and matched with typically developing individuals by 10-14 years of age. The NDD group also showed improved retention deficits in the paired association task at 10-14 years of age compared to the TD group. Conclusions: We showed that web-based learning testing using simple picture association is feasible for children with TD, as well as with NDD. We showed how web-based testing allows us to train children to learn the association between pictures, as shown in immediate test results and those completed 1 day after. This is important as many models for learning deficits in NDD target both short- and long-term memory for therapeutic intervention. We also demonstrated that despite potential confounding factors, such as self-reported diagnosis bias, technical issues, and varied participation, the Memory Game shows significant differences between typically developing children and those with NDD. Future experiments will leverage this potential of web-based testing for larger cohorts and cross-validation with other clinical or preclinical cognitive tasks.


  • Open Access

    Identifying Potential Gamification Elements for A New Chatbot for Families With Neurodevelopmental Disorders: User-Centered Design Approach

    by Truong An Bui, Megan Pohl, Cory Rosenfelt, Tatiana Ogourtsova, Mahdieh Yousef, Kerri Whitlock, Annette Majnemer, David Nicholas, Carrie Demmans Epp, Osmar Zaiane, et al.

    Background: Chatbots have been increasingly considered for applications in the health care field. However, it remains unclear how a chatbot can assist users with complex health needs, such as parents of children with neurodevelopmental disorders (NDDs) who need ongoing support. Often, this population must deal with complex and overwhelming health information, which can make parents less likely to use a software that may be very helpful. An approach to enhance user engagement is incorporating game elements in nongame contexts, known as gamification. Gamification needs to be tailored to users; however, there has been no previous assessment of gamification use in chatbots for NDDs. Objective: We sought to examine how gamification elements are perceived and whether their implementation in chatbots will be well received among parents of children with NDDs. We have discussed some elements in detail as the initial step of the project. Methods: We performed a narrative literature review of gamification elements, specifically those used in health and education. Among the elements identified in the literature, our health and social science experts in NDDs prioritized five elements for in-depth discussion: goal setting, customization, rewards, social networking, and unlockable content. We used a qualitative approach, which included focus groups and interviews with parents of children with NDDs (N=21), to assess the acceptability of the potential implementation of these elements in an NDD-focused chatbot. Parents were asked about their opinions on the 5 elements and to rate them. Video and audio recordings were transcribed and summarized for emerging themes, using deductive and inductive thematic approaches. Results: From the responses obtained from 21 participants, we identified three main themes: parents of children with NDDs were familiar with and had positive experiences with gamification; a specific element (goal setting) was important to all parents, whereas others (customization, rewards, and unlockable content) received mixed opinions; and the social networking element received positive feedback, but concerns about information accuracy were raised. Conclusions: We showed for the first time that parents of children with NDDs support gamification use in a chatbot for NDDs. Our study illustrates the need for a user-centered design in the medical domain and provides a foundation for researchers interested in developing chatbots for populations that are medically vulnerable. Future studies exploring wide range of gamification elements with large number of potential users are needed to understand the impact of gamification elements in enhancing knowledge mobilization.


  • Open Access

    Long-term Memory Testing in Children With Typical Development and Neurodevelopmental Disorders: Remote Web-based Image Task Feasibility Study (Preprint)

    by Truong An Bui, Cory Scott Rosenfelt, Kerri Hope Whitlock, Mickael Leclercq, Savannah Weber, Arnaud Droit, Sandra A Wiebe, Jacqueline Pei, Francois V Bolduc

    BACKGROUND Neurodevelopmental disorders (NDD) cause individuals to have difficulty in learning facts, procedures, or social skills. NDD has been linked to several genes, and several animal models have been used to identify potential therapeutic candidates based on specific learning paradigms for long-term and associative memory. In individuals with NDD, however, such testing has not been used so far, resulting in a gap in translating preclinical results to clinical practice. OBJECTIVE We aim to assess if individuals with NDD could be tested for paired association learning and long-term memory deficit, as shown in previous animal models. METHODS We developed an image-based paired association task, which can be performed at different time points using remote web-based testing, and evaluated its feasibility in children with typical development (TD), as well as NDD. We included 2 tasks: object recognition as a simpler task and paired association. Learning was tested immediately after training and also the next day for long-term memory. RESULTS We found that children aged 5-14 years with TD (n=128) and with NDD of different types (n=57) could complete testing using the Memory Game. Children with NDD showed deficits in both recognition and paired association tasks on the first day of learning, in both 5-9–year old (P<.001 and P=.01, respectively) and 10-14–year old groups (P=.001 and P<.001, respectively). The reaction times to stimuli showed no significant difference between individuals with TD or NDD. Children with NDD exhibited a faster 24-hour memory decay for the recognition task than those with TD in the 5-9–year old group. This trend is reversed for the paired association task. Interestingly, we found that children with NDD had their retention for recognition improved and matched with typically developing individuals by 10-14 years of age. The NDD group also showed improved retention deficits in the paired association task at 10-14 years of age compared to the TD group. CONCLUSIONS We showed that web-based learning testing using simple picture association is feasible for children with TD, as well as with NDD. We showed how web-based testing allows us to train children to learn the association between pictures, as shown in immediate test results and those completed 1 day after. This is important as many models for learning deficits in NDD target both short- and long-term memory for therapeutic intervention. We also demonstrated that despite potential confounding factors, such as self-reported diagnosis bias, technical issues, and varied participation, the Memory Game shows significant differences between typically developing children and those with NDD. Future experiments will leverage this potential of web-based testing for larger cohorts and cross-validation with other clinical or preclinical cognitive tasks. CLINICALTRIAL